James B. Breitmeyer serves as Executive at CADENCE PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, James B. Breitmeyer has executed 61 insider transactions totaling $1.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 17, 2009 involved exercising options for 1,000 shares valued at $3.2K.
James B. Breitmeyer currently holds 443,034 shares of CADENCE PHARMACEUTICALS INC (CADX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James B. Breitmeyer has been a net seller of CADX stock. They have purchased $86.0K and sold $1.5M worth of shares.
James B. Breitmeyer's most recent insider trade was on Dec 17, 2009, when they sold 1,000 shares at $3.20 per share.
Get notified when new Form 4 filings are submitted
| $10.00 |
| Discretionary |
| Nov 5, 2009 | CADX | $10.0K | Sale | 1,000 | $10.00 | Discretionary |
| Nov 5, 2009 | CADX | $3.2K | Option Exercise | 1,000 | $3.20 | Discretionary |
| Oct 1, 2009 | CADX | $11.0K | Sale | 1,000 | $10.96 | Discretionary |
| Oct 1, 2009 | CADX | $3.2K | Option Exercise | 1,000 | $3.20 | Discretionary |
| Sep 1, 2009 | CADX | $10.8K | Sale | 1,000 | $10.81 | Discretionary |
| Sep 1, 2009 | CADX | $3.2K | Option Exercise | 1,000 | $3.20 | Discretionary |
| Aug 3, 2009 | CADX | $12.1K | Sale | 1,000 | $12.11 | Discretionary |
| Aug 3, 2009 | CADX | $3.2K | Option Exercise | 1,000 | $3.20 | Discretionary |
| Feb 20, 2008 | CADX | $53.4K | Award | 10,000 | $5.34 | Discretionary |